# Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B in Perimenopausal Women.

> **NCT03897738** · NA · COMPLETED · sponsor: **I.M. Sechenov First Moscow State Medical University** · enrollment: 106 (actual)

## Conditions studied

- Perimenopause, Climacteric Syndrome

## Interventions

- **DIETARY_SUPPLEMENT:** Amberen
- **DIETARY_SUPPLEMENT:** Smart B
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT03897738
- **Lead sponsor:** I.M. Sechenov First Moscow State Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-30
- **Primary completion:** 2020-02-18
- **Final completion:** 2020-02-18
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03897738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03897738, "Clinical Evaluation of Effectiveness and Safety of Amberen and Smart B in Perimenopausal Women.". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT03897738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*